Publications by authors named "Kyle Matchett"

Claim this Profile
T
Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better.
Peter J Gawne, Helen E Bryant, Steven G DuBois, Sally L George, Juliet Gray, Kyle B Matchett

J Nucl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer" [Life Sci., 329 (2023) 121964].
Mohamed El-Tanani, Angela Platt-Higgins, Hamdi Nsairat, Ismail I Matalka, Khaled Abdul-Aziz Ahmed, Kyle B Matchett

Life Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of Ran as a prognostic marker in stage I and stage II primary breast cancer.
Mohamed El-Tanani, Angela Platt-Higgins, Hamdi Nsairat, Ismail I Matalka, Khaled Abdul-Aziz Ahmed, Kyle B Matchett

Life Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of the SIRT1 response to exercise.
Ciara Gallardo Juan, Kyle B Matchett, Gareth W Davison

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulating RALA/Au nanocomplexes to enhance nanoparticle internalisation efficiency, sensitising prostate tumour models to radiation treatment.
Lindsey A Bennie, Jie Feng, Christopher Emmerson, Wendy B Hyland, Kyle B Matchett

J Nanobiotechnology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiplex Screening for Interacting Compounds in Paediatric Acute Myeloid Leukaemia.
Lauren V Cairns, Katrina M Lappin, Alexander Mutch, Ahlam Ali, Kyle B Matchett

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A compound combination screening approach with potential to identify new treatment options for paediatric acute myeloid leukaemia.
Katrina M Lappin, Lindsay Davis, Kyle B Matchett, Yubin Ge, Ken I Mills

Sci Rep· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tibetan , an allele with loss-of-function properties.
Daisheng Song, Bradleigh E Navalsky, Wei Guan, Cassandra Ingersoll, Tao Wang, Kyle B Matchett

Proc Natl Acad Sci U S A· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Ran-RCC1 Inhibitory Peptide-Loaded Nanoparticles Have Anti-Cancer Efficacy In Vitro and In Vivo.
Yusuf A Haggag, Kyle B Matchett, Robert A Falconer, Mohammad Isreb, Jason Jones

Cancers (Basel)· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Invasive and Anti-Proliferative Effects of shRNA-Loaded Poly(Lactide-Co-Glycolide) Nanoparticles Following RAN Silencing in MDA-MB231 Breast Cancer Cells.
Ankur Sharma, Paul McCarron, Kyle Matchett, Susan Hawthorne, Mohamed El-Tanani

Pharm Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermal Delivery of a Near-Infrared Photosensitizer Using Dissolving Microneedle Arrays.
Iman M N Hamdan, Ismaiel A Tekko, Kyle B Matchett, Luis G Arnaut, Claudia S Silva

J Pharm Sci· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Precision Medicine: Tailoring Individualized Therapies.
Kyle B Matchett, Niamh Lynam-Lennon, R William Watson, James A L Brown

Cancers (Basel)· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapy.
Jodie F Hay, Katrina Lappin, Fabio Liberante, Laura M Kettyle, Kyle B Matchett

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythropoietin drives breast cancer progression by activation of its receptor EPOR.
Ka Kui Chan, Kyle B Matchett, Jonathan A Coulter, Hiu-Fung Yuen, Cian M McCrudden

Oncotarget· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells.
Yusuf A Haggag, Kyle B Matchett, El-Habib Dakir, Paul Buchanan, Mohammed A Osman

Int J Pharm· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose salinomycin induces anti-leukemic responses in AML and MLL.
Gary D R Roulston, Charlotte L Burt, Laura M J Kettyle, Kyle B Matchett, Heather L Keenan

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ran GTPase promotes cancer progression via Met recepto-rmediated downstream signaling.
Hiu-Fung Yuen, Ka-Kui Chan, Angela Platt-Higgins, el-Habib Dakir, Kyle B Matchett

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Big Data-Led Cancer Research, Application, and Insights.
James A L Brown, Triona Ni Chonghaile, Kyle B Matchett, Niamh Lynam-Lennon, Patrick A Kiely

Cancer Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein deregulation associated with breast cancer metastasis.
Ka Kui Chan, Kyle B Matchett, Paul M McEnhill, El Habib Dakir, Mary Frances McMullin

Cytokine Growth Factor Rev· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation.
Perry Maxwell, Florinda Melendez-Rodríguez, Kyle B Matchett, Julian Aragones, Nathalie Ben-Califa

Br J Haematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ran GTPase in nuclear envelope formation and cancer metastasis.
Kyle B Matchett, Suzanne McFarlane, Sophie E Hamilton, Yousef S A Eltuhamy, Matthew A Davidson

Adv Exp Med Biol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.
Kienan I Savage, Kyle B Matchett, Eliana M Barros, Kevin M Cooper, Gareth W Irwin

Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinicopathological markers of prognosis in breast cancer.
David P Boyle, Clare M McCourt, Kyle B Matchett, Manuel Salto-Tellez

Expert Rev Mol Diagn· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis